Terumo Corporation

4543

JP3546800008

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-19 am EDT			5-day change	1st Jan Change
2,538 ^JPY	-1.40%		-3.06%	+9.84%

Apr. 12	Penumbra, Inc. : The underdog in healthcare
Mar. 18	Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation	CI

Terumo Corporation Provides Dividend Guidance for the Year Ending March 2022

May 12, 2021 at 02:42 am EDT

Terumo Corporation provided dividend guidance of JPY 15.00 per share for the year ending March 2022 compared to JPY 15.00 per share paid a year ago.

Latest news about Terumo Corporation

Penumbra, Inc. : The underdog in healthcare	Apr. 11
Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation	Mar. 17	CI
Jefferies Adjusts Terumo’s Price Target to 6,700 Yen From 5,300 Yen, Keeps at Buy	Mar. 13	MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.	Mar. 11	CI
Terumo Corporation's Equity Buyback announced on August 9, 2023, has closed with 3,380,000 shares, representing 0.45% for ¥11,097.09 million.	Mar. 07	CI
Terumo Repurchases 521 Million Yen Shares in February	Mar. 04	MT
Terumo Corp to Undertake One-to-Two Share Split	Feb. 08	MT
Terumo's Attributable Profit Climbs 13.8% in Fiscal Nine Months	Feb. 07	MT
Transcript : Terumo Corporation, Q3 2024 Earnings Call, Feb 07, 2024	Feb. 07
Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023	Feb. 07	CI
Terumo Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 07	CI
Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Feb. 07	CI
Terumo Reacquires Over 500,000 Shares in January	Feb. 05	MT
Terumo Repurchases Shares	Jan. 10	MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.	Jan. 09	CI
Jefferies Adjusts Terumo's Price Target to 5,300 Yen From 4,500 Yen, Keeps at Buy	Jan. 04	MT
Hikaru Samejima to Assume Position as President and CEO of Terumo Corp. in April 2024	Dec. 14	MT
Shinjiro Sato to Leave as CEO of Terumo Corporation on April 1, 2024	Dec. 14	CI
Terumo Corporation Announces Management Changes, Effective from April 1, 2024	Dec. 14	CI
Terumo Repurchases 629,300 Shares in November	Dec. 04	MT
Transcript : Terumo Corporation, Q2 2024 Earnings Call, Nov 15, 2023	Nov. 15
Japanese Shares Continue Winning Streak on Wednesday Amid Rising Hopes on US Rate-Hike Pause	Nov. 15	MT
Japan's Nikkei jumps 2% on strong earnings, dovish Fed bets	Nov. 14	RE
Terumo's Fiscal H1 Attributable Profit Climbs on Strong Infusion, Catheter Product Sales; Shares Surge 10%	Nov. 14	MT
Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 14	CI

Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows: - cardiac surgery devices (53.5%); - medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.; - sanguine transfusion equipments (17.9%). Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-14 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Terumo Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,574 JPY

Average target price

2,951 JPY

Spread / Average Target

+14.62%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
TERUMO CORPORATION	+9.84%	24.73B
ABBOTT LABORATORIES	-2.60%	183B
MEDTRONIC PLC	-3.61%	105B
DEXCOM, INC.	+6.29%	51.77B
CENCORA, INC.	+16.26%	47.29B
HOYA CORPORATION	-1.73%	40.2B
WEST PHARMACEUTICAL SERVICES, INC.	+7.03%	27.62B
METTLER-TOLEDO INTERNATIONAL, INC.	-1.61%	25.51B
ZIMMER BIOMET HOLDINGS, INC.	-2.03%	24.52B
ALIGN TECHNOLOGY, INC.	+10.09%	22.68B

Other Medical Equipment, Supplies & Distribution